Skip to main content
Top
Published in: Diabetology International 4/2020

01-10-2020 | Insulins | Short Communication

Effect of tasteless calorie-free gum chewing before meal on postprandial plasma glucose, insulin, glucagon, and gastrointestinal hormones in Japanese men without diagnosed glucose metabolism disorder: a pilot randomized crossover trial

Authors: Mitsuyoshi Takahara, Masahiro Fukuda, Yuji Matsuzawa, Iichiro Shimomura

Published in: Diabetology International | Issue 4/2020

Login to get access

Abstract

This pilot study aimed to examine the effect of pre-meal tasteless calorie-free gum chewing on post-meal blood levels of glucose, insulin, glucagon, and gastrointestinal hormones. This was an open-label, randomized, 2-sequence, 3-period, 2-treatment crossover trial with a 1:1 allocation. Sixteen Japanese adult male volunteers aged between 30 and 49 years without diagnosed glucose metabolism disorder were enrolled. Ingestion of 200-g cooked rice after 15-min tasteless calorie-free gum chewing (GUM+ treatment) was compared to that without preceding gum chewing (GUM− treatment). Cooked rice was divided into twelve equally sized portions and consumed by chewing each portion 30 times before swallowing. Treatment sessions were separated by an at least 1-week interval and attended after an overnight fast. Circulating levels of glucose, insulin, glucagon, active glucagon-like peptide (GLP)-1 and ghrelin were measured at baseline (before treatment) and 0, 15, 30, 60, and 120 min after completion of the meal ingestion, and the postprandial change from baseline was assessed. As a result, the change in glucose levels at 0 min was significantly lower in the GUM+ treatment than in the GUM− treatment (P = 0.004). Furthermore, the GUM+ treatment demonstrated higher incremental insulin levels at 15 min (P = 0.041) and higher incremental active GLP-1 levels at 30 and 60 min (P = 0.018 and 0.021, respectively); whereas, postprandial glucagon and ghrelin levels were not significantly different. In conclusion, the current pilot study demonstrated that tasteless calorie-free gum chewing before rice eating had a significant but limited impact on the increase of postprandial active GLP-1 levels in male individuals without diagnosed glucose metabolism disorder.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li J, Zhang N, Hu L, Li Z, Li R, Li C, et al. Improvement in chewing activity reduces energy intake in one meal and modulates plasma gut hormone concentrations in obese and lean young Chinese men. Am J Clin Nutr. 2011;94:709–16.CrossRef Li J, Zhang N, Hu L, Li Z, Li R, Li C, et al. Improvement in chewing activity reduces energy intake in one meal and modulates plasma gut hormone concentrations in obese and lean young Chinese men. Am J Clin Nutr. 2011;94:709–16.CrossRef
2.
go back to reference Sonoki K, Iwase M, Takata Y, Nakamoto T, Masaki C, Hosokawa R, et al. Effects of thirty-times chewing per bite on secretion of glucagon-like peptide-1 in healthy volunteers and type 2 diabetic patients. Endocr J. 2013;60:311–9.CrossRef Sonoki K, Iwase M, Takata Y, Nakamoto T, Masaki C, Hosokawa R, et al. Effects of thirty-times chewing per bite on secretion of glucagon-like peptide-1 in healthy volunteers and type 2 diabetic patients. Endocr J. 2013;60:311–9.CrossRef
3.
go back to reference Zhu Y, Hsu WH, Hollis JH. Increasing the number of masticatory cycles is associated with reduced appetite and altered postprandial plasma concentrations of gut hormones, insulin and glucose. Br J Nutr. 2013;110:384–90.CrossRef Zhu Y, Hsu WH, Hollis JH. Increasing the number of masticatory cycles is associated with reduced appetite and altered postprandial plasma concentrations of gut hormones, insulin and glucose. Br J Nutr. 2013;110:384–90.CrossRef
4.
go back to reference Xu J, Xiao X, Li Y, Zheng J, Li W, Zhang Q, et al. The effect of gum chewing on blood GLP-1 concentration in fasted, healthy, non-obese men. Endocrine. 2015;50:93–8.CrossRef Xu J, Xiao X, Li Y, Zheng J, Li W, Zhang Q, et al. The effect of gum chewing on blood GLP-1 concentration in fasted, healthy, non-obese men. Endocrine. 2015;50:93–8.CrossRef
5.
go back to reference Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E (2018) Japanese clinical practice guideline for diabetes 2016. Diabetol Int 9(1):1–45CrossRef Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E (2018) Japanese clinical practice guideline for diabetes 2016. Diabetol Int 9(1):1–45CrossRef
6.
go back to reference Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care. 2009;32:2184–6.CrossRef Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care. 2009;32:2184–6.CrossRef
7.
go back to reference Matsuo T, Miyagawa J, Kusunoki Y, Miuchi M, Ikawa T, Akagami T, et al. Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay. J Diabetes Investig. 2016;7:324–31.CrossRef Matsuo T, Miyagawa J, Kusunoki Y, Miuchi M, Ikawa T, Akagami T, et al. Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay. J Diabetes Investig. 2016;7:324–31.CrossRef
8.
go back to reference Yabe D, Watanabe K, Sugawara K, Kuwata H, Kitamoto Y, Sugizaki K, et al. Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes. J Diabetes Investig. 2012;3:70–9.CrossRef Yabe D, Watanabe K, Sugawara K, Kuwata H, Kitamoto Y, Sugizaki K, et al. Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes. J Diabetes Investig. 2012;3:70–9.CrossRef
9.
go back to reference Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia. 2011;54:10–8.CrossRef Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia. 2011;54:10–8.CrossRef
10.
go back to reference Koopman ADM, Rutters F, Rauh SP, Nijpels G, Holst JJ, Beulens JW, et al. Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: the Hoorn Meal Study. PLoS ONE. 2018;13:e0191114.CrossRef Koopman ADM, Rutters F, Rauh SP, Nijpels G, Holst JJ, Beulens JW, et al. Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: the Hoorn Meal Study. PLoS ONE. 2018;13:e0191114.CrossRef
11.
go back to reference Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, et al. Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Diabetes Care. 2013;36:3276–82.CrossRef Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, et al. Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Diabetes Care. 2013;36:3276–82.CrossRef
13.
go back to reference le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399–409.CrossRef le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399–409.CrossRef
14.
go back to reference Suzuki H, Fukushima M, Okamoto S, Takahashi O, Shimbo T, Kurose T, et al. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects. Metabolism. 2005;54:1593–9.CrossRef Suzuki H, Fukushima M, Okamoto S, Takahashi O, Shimbo T, Kurose T, et al. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects. Metabolism. 2005;54:1593–9.CrossRef
15.
go back to reference Ranawana V, Clegg ME, Shafat A, Henry CJ. Postmastication digestion factors influence glycemic variability in humans. Nutr Res. 2011;31:452–9.CrossRef Ranawana V, Clegg ME, Shafat A, Henry CJ. Postmastication digestion factors influence glycemic variability in humans. Nutr Res. 2011;31:452–9.CrossRef
16.
go back to reference Herrmann-Rinke C, Voge A, Hess M, Goke B. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J Endocrinol. 1995;147:25–31.CrossRef Herrmann-Rinke C, Voge A, Hess M, Goke B. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J Endocrinol. 1995;147:25–31.CrossRef
17.
go back to reference Hansen L, Lampert S, Mineo H, Holst JJ. Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab. 2004;287:E939–E947947.CrossRef Hansen L, Lampert S, Mineo H, Holst JJ. Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab. 2004;287:E939–E947947.CrossRef
18.
go back to reference Anini Y, Brubaker PL. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology. 2003;144:3244–50.CrossRef Anini Y, Brubaker PL. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology. 2003;144:3244–50.CrossRef
19.
go back to reference Ohta M, Ueda T, Sakurai K. Effect of chewing or compressing food on autonomic nervous activity in older adults. Gerodontology. 2017;34:434–40.CrossRef Ohta M, Ueda T, Sakurai K. Effect of chewing or compressing food on autonomic nervous activity in older adults. Gerodontology. 2017;34:434–40.CrossRef
20.
go back to reference Hopman WP, Jansen JB, Rosenbusch G, Lamers CB. Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion. 1987;38:197–203.CrossRef Hopman WP, Jansen JB, Rosenbusch G, Lamers CB. Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion. 1987;38:197–203.CrossRef
21.
go back to reference Ostoft SH, Bagger JI, Hansen T, Hartmann B, Pedersen O, Holst JJ, et al. Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young. Eur J Endocrinol. 2015;173:205–15.CrossRef Ostoft SH, Bagger JI, Hansen T, Hartmann B, Pedersen O, Holst JJ, et al. Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young. Eur J Endocrinol. 2015;173:205–15.CrossRef
22.
go back to reference Idorn T, Knop FK, Jorgensen MB, Christensen M, Holst JJ, Hornum M, et al. Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease. J Clin Endocrinol Metab. 2014;99:2457–66.CrossRef Idorn T, Knop FK, Jorgensen MB, Christensen M, Holst JJ, Hornum M, et al. Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease. J Clin Endocrinol Metab. 2014;99:2457–66.CrossRef
23.
go back to reference Smeets PA, Erkner A, de Graaf C. Cephalic phase responses and appetite. Nutr Rev. 2010;68:643–55.CrossRef Smeets PA, Erkner A, de Graaf C. Cephalic phase responses and appetite. Nutr Rev. 2010;68:643–55.CrossRef
Metadata
Title
Effect of tasteless calorie-free gum chewing before meal on postprandial plasma glucose, insulin, glucagon, and gastrointestinal hormones in Japanese men without diagnosed glucose metabolism disorder: a pilot randomized crossover trial
Authors
Mitsuyoshi Takahara
Masahiro Fukuda
Yuji Matsuzawa
Iichiro Shimomura
Publication date
01-10-2020
Publisher
Springer Singapore
Keywords
Insulins
Insulins
Published in
Diabetology International / Issue 4/2020
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-020-00435-9

Other articles of this Issue 4/2020

Diabetology International 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine